Your browser doesn't support javascript.
loading
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Shribman, Samuel; Heller, Carolin; Burrows, Maggie; Heslegrave, Amanda; Swift, Imogen; Foiani, Martha S; Gillett, Godfrey T; Tsochatzis, Emmanuel A; Rowe, James B; Gerhard, Alex; Butler, Chris R; Masellis, Mario; Bremner, Fion; Martin, Alison; Jung, Lynne; Cook, Paul; Zetterberg, Henrik; Bandmann, Oliver; Rohrer, Jonathan D; Warner, Thomas T.
Afiliação
  • Shribman S; Department of Clinical and Movement Neurosciences, Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Heller C; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Burrows M; Department of Neurodegenerative Disease, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Heslegrave A; Department of Clinical and Movement Neurosciences, Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Swift I; Department of Neurodegenerative Disease, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Foiani MS; Department of Neurodegenerative Disease, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Gillett GT; Department of Neurodegenerative Disease, UK Dementia Research Institute, UCL Queen Square Institute of Neurology, London, United Kingdom.
  • Tsochatzis EA; Department of Clinical Chemistry, Northern General Hospital, Sheffield, United Kingdom.
  • Rowe JB; UCL Institute for Liver and Digestive Health, Royal Free Hospital and UCL, London, United Kingdom.
  • Gerhard A; Department of Clinical Neurosciences, University of Cambridge and Cambridge University Hospitals Trust, Cambridge, United Kingdom.
  • Butler CR; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester, United Kingdom.
  • Masellis M; Departments of Geriatric Medicine and Nuclear Medicine, University of Duisburg-Essen, Duisburg, Germany.
  • Bremner F; Department of Brain Sciences, Imperial College London, London, United Kingdom.
  • Martin A; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
  • Jung L; Departamento de Neurología, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Cook P; Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Zetterberg H; Neuro-Ophthalmology, National Hospital for Neurology and Neurosurgery, London, United Kingdom.
  • Bandmann O; Department of Clinical Chemistry, Northern General Hospital, Sheffield, United Kingdom.
  • Rohrer JD; Department of Clinical Biochemistry, Southampton General Hospital, Southampton, United Kingdom.
  • Warner TT; Department of Clinical Biochemistry, Southampton General Hospital, Southampton, United Kingdom.
Mov Disord ; 36(2): 503-508, 2021 02.
Article em En | MEDLINE | ID: mdl-33078859
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Degeneração Hepatolenticular Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article